A randomized, double-blind comparison of
โ
Suzanne H. Stephens; V. Lee Silvey; Richard H. Wheeler
๐
Article
๐
1990
๐
John Wiley and Sons
๐
English
โ 414 KB
๐ 1 views
Thirty-seven patients with advanced incurable malignancies who were receiving their first course of cisplatin (2 90 mg/mz bolus), alone or in combination with other antineoplastic agents, were entered in this randomized, double-blind study to determine the antiemetic efficacy of the addition of high